Home Health Monitoring Devices
•16 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (16)
%
| Company | Market Cap | Price |
|---|---|---|
|
Home health monitoring devices used for at-home dialysis therapies and remote patient monitoring.
|
$15.80B |
$53.85
|
|
Home health monitoring devices fit Masimo's strategy to expand monitoring into remote/home settings beyond hospital use.
|
$7.84B |
$144.64
-4.29%
|
|
Enables at-home health monitoring using wearable device and connected software.
|
$5.63B |
$176.20
-1.06%
|
|
The business includes home-health devices used for patient monitoring and at-home care, aligning with the Home Health Monitoring Devices category.
|
$1.17B |
$8.70
-3.65%
|
|
At-home health monitoring devices; WCD worn by patient at home with remote monitoring.
|
$1.13B |
$22.00
-6.82%
|
|
At-home health monitoring capabilities and portable diabetes management hardware align with home health monitoring devices.
|
$911.78M |
$21.03
-7.72%
|
|
Home Health Monitoring Devices: Core home-use medical devices (pneumatic compression devices and AffloVest) used for home therapy.
|
$330.59M |
$14.22
-2.40%
|
|
Ventilator and other home medical equipment rentals/sales align with the Home Health Monitoring Devices category (at-home medical devices).
|
$265.20M |
$6.71
+0.75%
|
|
SmartVest therapy devices are deployed in home-care settings, aligning with the Home Health Monitoring Devices category.
|
$210.24M |
$25.07
+1.79%
|
|
Home Health Monitoring Devices represent the at-home health monitoring product line stemming from HealthBeacon.
|
$188.94M |
$13.80
-2.82%
|
|
Home health monitoring devices align with at-home remote health management capabilities.
|
$92.01M |
$5.82
-5.98%
|
|
Oxygen concentrators and other home-use health devices fit under Home Health Monitoring Devices.
|
$67.54M |
$0.42
-9.81%
|
|
Home health monitoring devices and related remote health tracking capabilities align with ECOR's at-home health platform offerings.
|
$37.10M |
$5.00
-5.12%
|
|
NXGEL's consumer health focus could extend to home health monitoring devices leveraging hydrogel-based sensors or interfaces.
|
$19.67M |
$2.57
-3.02%
|
|
CGM technology targets home-based diabetes management, categorized as Home Health Monitoring Devices.
|
$10.69M |
$0.55
-9.02%
|
|
AppYea directly manufactures/markets at-home wearables for sleep monitoring (AppySleep).
|
$10.37M |
$0.02
-13.97%
|
Loading industry metrics...
Loading comparison data...
